Santa Ana Bio

Last updated: November 16, 2025

CEO - Peter Emtage

Country: USA | Funding: $176M (+)
Founded: 2022

Website: https://www.santaanabio.com

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Competitors

Apogee Therapeutics

Nimbus Therapeutics

Acelyrin